With the analysis among 18,753 patents, we discovered top 445 key players by total patent application. Anacor Pharmaceuticals LLC, China Petroleum & Chemical Corp., Nektar Therapeutics are dominant in this area. They take 3.48% of the total patent filing.
Anacor Pharmaceuticals LLC
California, United States
Patent: 262
China Petroleum & Chemical Corp.
Beijing Shi, China
Patent: 139
California, United States
Patent: 136
F. Hoffmann-La Roche Ltd.
North Carolina, United States
Patent: 125
California, United States
Patent: 114
The General Hospital Corp.
Massachusetts, United States
Patent: 110
Antwerpen, Belgium
Patent: 108
Basel-Stadt, Switzerland
Patent: 106
Skyhawk Therapeutics, Inc.
Massachusetts, United States
Patent: 94
With the analysis among 693 patents, we discovered top 107 start-ups by total patent application. Skyhawk Therapeutics, Inc., Morphic Therapeutic, Inc., Institut National de la Santé et de la Recherche Médicale are active in this area.
Skyhawk Therapeutics, Inc.
Massachusetts, United States
Patent: 94
Morphic Therapeutic, Inc.
Massachusetts, United States
Patent: 89
Institut National de la Santé et de la Recherche Médicale
California, United States
Patent: 25
Intarcia Therapeutics, Inc.
California, United States
Patent: 21
California, United States
Patent: 17
Saskatchewan, Canada
Patent: 17
California, United States
Patent: 13
With the analysis among related 14,795 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Zhejiang University, Regents of The University of Michigan, Dana-Farber Cancer Institute, Inc. take 2.78% of patent filing during this period.
Zhejiang Sheng, China
Patent: 148
Regents of The University of Michigan
Michigan, United States
Patent: 132
Dana-Farber Cancer Institute, Inc.
Massachusetts, United States
Patent: 131
South China University of Technology
Guangdong Sheng, China
Patent: 126
Jiangsu Sheng, China
Patent: 119
Regents of the University of California
California, United States
Patent: 115
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 102
Guangdong Sheng, China
Patent: 100
Skyhawk Therapeutics, Inc.
Massachusetts, United States
Patent: 94
Shanghai Shi, China
Patent: 92
With the analysis among related 14,795 patents in last 5 years, we discover 149 new entrants. Skyhawk Therapeutics, Inc., Morphic Therapeutic, Inc., Akebia Therapeutics, Inc. are the most active new entrants in this area.
Skyhawk Therapeutics, Inc.
Massachusetts, United States
Patent: 94
Morphic Therapeutic, Inc.
Massachusetts, United States
Patent: 89
Akebia Therapeutics, Inc.
Massachusetts, United States
Patent: 34
West China Hospital of Sichuan University
Hovedstaden, Denmark
Patent: 24
Guangzhou Maxinovel Pharmaceiticals Co Ltd
Guangdong Sheng, China
Patent: 24
R.P. Scherer Technologies LLC
Nevada, United States
Patent: 23
Shanghai Synergy Pharmaceutical Sciences Co., Ltd
Shanghai Shi, China
Patent: 22
Tangshan Peptide Jingtang Biotechnology Co., Ltd.
Hebei Sheng, China
Patent: 22
Denali Therapeutics, Inc.
California, United States
Patent: 21
With the analysis among 14,449 patents, we discovered top 331 universities and scientific research institutions by total patent application. The Scripps Research Institute, President & Fellows of Harvard College, Zhejiang University are dominant in this area. They take 7.58% of the total patent filing.
The Scripps Research Institute
California, United States
Patent: 286
President & Fellows of Harvard College
Massachusetts, United States
Patent: 244
Zhejiang Sheng, China
Patent: 214
South China University of Technology
Guangdong Sheng, China
Patent: 200
Shanghai Shi, China
Patent: 187
Jiangsu Sheng, China
Patent: 163
Connecticut, United States
Patent: 161
Massachusetts Institute of Technology
Massachusetts, United States
Patent: 154
Sichuan Sheng, China
Patent: 138
Guangdong Sheng, China
Patent: 130